2025. Efficacy of Rosuvastatin vs Atorvastatin in High Risk Dyslipidemic Patients. Physical Education, Health and Social Sciences. 3, 2 (Jun. 2025), 916–922. DOI:https://doi.org/10.63163/jpehss.v3i2.454.